National and Kapodistrian University of Athens
Αξιολόγηση της αποτελεσματικότητας της τιγεκυκλίνης σε πειραματικό μοντέλο εντεροκοκκίνης ενδοκαρδίτιδας
Abstract
dc:descriptionEnterococci are among the most frequent etiologic agents of infective endocarditis, and therapeuticproblems arise from its inherent trend to accumulate resistance mechanisms. We evaluated the efficacy oftigecycline alone and in combination with gentamicin in a rabbit model of endocarditis caused by a linezolidand vancomycin resistant strain of Enterococcus faecium.Rabbits with induced enterococcal endocarditis were randomized to 4 groups: control group (n=14),gentamicin 6mg/kg subcutaneously once daily (n=15), tigecycline 4mg/kg intravenously twice daily (n=15),tigecycline plus gentamicin at the same dosing regimens (n=15). Treatment duration was five days. In orderto test the possibility of relapse another two groups were studied that received tigecycline (n=13) ortigecycline plus gentamicin (n=12). These animals were sacrificed 5 days after the end of antimicrobialtreatment. Post sacrifice, qualitative and quantitative cultures of excised vegetations and peripheral tissuespecimens (lung, liver, spleen and kidney) were performed.Tigecycline MIC for the selected strain was 0.06 mg/L and proved bactericidal in time-kill study.Tigecycline-treated animals had less microbial counts in excised vegetations compared with control andgentamicin-treated animals (log10cfu/g: 5.21 vs. 8.02 and 8.12, respectively, p<0.001). Addition of gentamicincaused a further, statistically non-significant, reduction in colony counts (log10 cfu/g: 3.93, p=0.23 vs.tigecycline). No strains recovered from vegetations exhibited resistance to tigecycline. Analogous results Enterococci are among the most frequent etiologic agents of infective endocarditis, and therapeuticproblems arise from its inherent trend to accumulate resistance mechanisms. We evaluated the efficacy oftigecycline alone and in combination with gentamicin in a rabbit model of endocarditis caused by a linezolidand vancomycin resistant strain of Enterococcus faecium.Rabbits with induced enterococcal endocarditis were randomized to 4 groups: control group (n=14),gentamicin 6mg/kg subcutaneously once daily (n=15), tigecycline 4mg/kg intravenously twice daily (n=15),tigecycline plus gentamicin at the same dosing regimens (n=15). Treatment duration was five days. In orderto test the possibility of relapse another two groups were studied that received tigecycline (n=13) ortigecycline plus gentamicin (n=12). These animals were sacrificed 5 days after the end of antimicrobialtreatment. Post sacrifice, qualitative and quantitative cultures of excised vegetations and peripheral tissuespecimens (lung, liver, spleen and kidney) were performed.Tigecycline MIC for the selected strain was 0.06 mg/L and proved bactericidal in time-kill study.Tigecycline-treated animals had less microbial counts in excised vegetations compared with control andgentamicin-treated animals (log10cfu/g: 5.21 vs. 8.02 and 8.12, respectively, p<0.001). Addition of gentamicincaused a further, statistically non-significant, reduction in colony counts (log10 cfu/g: 3.93, p=0.23 vs.tigecycline). No strains recovered from vegetations exhibited resistance to tigecycline. Analogous results were documented regarding lung, liver, spleen and kidney tissue cultures. No increase in bacterial load wasdocumented in the two test-of-relapse groups.In conclusion, tigecycline proved effective in reducing vegetation bacterial load and sterilizing peripheralorgans in a rabbit model of endocarditis, caused by linezolid and vancomycin resistant E.faecium, even fivedays after completion of therapy. In vitro or in vivo synergy or antagonism with gentamicin was not shown.Tigecycline could be part of a combination regimen for the treatment of clinical infective endocarditis due tomultiresistant strains of enterococci.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pontikis, Konstantinos
- Ποντίκης, Κωνσταντίνος
Subjects
dc:subject × 18- Εντεροκοκκική ενδοκαρδίτιδα
- Ζωικό μοντέλο
- Πολυανθεκτιτοί εντερέκοκκοι
- Τιγεκυκλίνη
- Γενταμικίνη
- Συνέργεια
- Συνδυαστική θεραπεία
- Enterococcal endocarbitis
- Rabbir model
- MDR enterococci
- Tigecycline
- Gentamicin
- Synergy
- Combination therapy
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41333